Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
3
×
fda
3
×
life sciences
national blog main
bluebird bio
boston blog main
boston top stories
clinical trials
gene therapy
hemophilia
national top stories
new york blog main
new york top stories
raleigh-durham blog main
san francisco blog main
san francisco top stories
spark therapeutics
achromatopsia
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
beta-thalassemia
bill cassidy
biomarin pharmaceutical
biotech
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
competitive generic therapy
cystic fibrosis
detroit blog main
detroit top stories
dna
food and drug administration
gout
harvard pilgrim health care
What
therapy
3
×
deal
drug
gene
age
aren’t
bigger
biggest
bio
building
come
developer
developers
disease
drugs
emerging
established
fda
firm
gave
help
imminent
j
johnson
long
lung
medicare
meiragtx
momentum
morning
moves
news
noteworthy
pah
past
patients
prices
rare
reaches
rivalry
Language
Current search:
deals
×
fda
×
therapy
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
